WallStreetZenWallStreetZen

NYSE: STE
Steris PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their STE stock forecasts and price targets.

Forecast return on equity

Is STE forecast to generate an efficient return?

Company
16.7%
Industry
29.18%
Market
168.43%
STE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is STE forecast to generate an efficient return on assets?

Company
11.28%
Industry
14.34%
STE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

STE earnings per share forecast

What is STE's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$11.21+55.67%
Avg 2 year Forecast
$12.31+70.91%
Avg 3 year Forecast
$12.18+69.18%
STE's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

STE revenue forecast

What is STE's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$6.4B+9.43%
Avg 2 year Forecast
$6.8B+17.07%
Avg 3 year Forecast
$7.2B+23.13%
STE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

STE earnings growth forecast

How is STE forecast to perform vs Medical Devices companies and vs the US market?

Company
20.95%
Industry
23.91%
Market
34.1%
STE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
STE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
STE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

STE revenue growth forecast

How is STE forecast to perform vs Medical Devices companies and vs the US market?

Company
7.39%
Industry
8.99%
Market
13.71%
STE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STE vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
STE$216.88N/AN/A
DXCM$59.55$83.75+40.64%Strong Buy
PHG$26.34N/AN/A
ZBH$82.43$99.20+20.34%Hold
SNN$30.93$35.00+13.16%Hold
View Top Medical Device Stocks

Steris Stock Forecast FAQ

What is STE's earnings growth forecast for 2027-2029?

(NYSE: STE) Steris's forecast annual earnings growth rate of 20.95% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 23.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.1%.

Steris's earnings in 2026 is $707,872,000.On average, 11 Wall Street analysts forecast STE's earnings for 2027 to be $1,099,244,495, with the lowest STE earnings forecast at $1,025,050,739, and the highest STE earnings forecast at $1,158,511,233. On average, 8 Wall Street analysts forecast STE's earnings for 2028 to be $1,206,832,798, with the lowest STE earnings forecast at $1,119,722,560, and the highest STE earnings forecast at $1,278,996,401.

In 2029, STE is forecast to generate $1,194,612,650 in earnings, with the lowest earnings forecast at $1,159,129,105 and the highest earnings forecast at $1,241,924,042.

If you're new to stock investing, here's how to buy Steris stock.

What is STE's revenue growth forecast for 2027-2029?

(NYSE: STE) Steris's forecast annual revenue growth rate of 7.39% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.99%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.71%.

Steris's revenue in 2026 is $5,828,131,000.On average, 11 Wall Street analysts forecast STE's revenue for 2027 to be $625,522,509,450, with the lowest STE revenue forecast at $596,100,001,950, and the highest STE revenue forecast at $657,102,667,500. On average, 8 Wall Street analysts forecast STE's revenue for 2028 to be $669,165,895,575, with the lowest STE revenue forecast at $644,352,914,250, and the highest STE revenue forecast at $707,317,080,300.

In 2029, STE is forecast to generate $703,786,379,400 in revenue, with the lowest revenue forecast at $682,896,399,075 and the highest revenue forecast at $731,639,686,500.

What is STE's forecast return on assets (ROA) for 2027-2029?

(NYSE: STE) forecast ROA is 11.28%, which is lower than the forecast US Medical Devices industry average of 14.34%.

What is STE's Earnings Per Share (EPS) forecast for 2027-2029?

(NYSE: STE) Steris's current Earnings Per Share (EPS) is $7.20. On average, analysts forecast that STE's EPS will be $11.21 for 2027, with the lowest EPS forecast at $10.45, and the highest EPS forecast at $11.81. On average, analysts forecast that STE's EPS will be $12.31 for 2028, with the lowest EPS forecast at $11.42, and the highest EPS forecast at $13.04. In 2029, STE's EPS is forecast to hit $12.18 (min: $11.82, max: $12.66).

What is STE's forecast return on equity (ROE) for 2027-2029?

(NYSE: STE) forecast ROE is 16.7%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.